These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33961422)

  • 1. RGD-Peptide Functionalization Affects the
    Gambino G; Gambino T; Connah L; La Cava F; Evrard H; Angelovski G
    J Med Chem; 2021 Jun; 64(11):7565-7574. PubMed ID: 33961422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of bioresponsive chelates and perfluorinated lipid nanoparticles enables in vivo MRI probe quantification.
    Gambino G; Gambino T; Angelovski G
    Chem Commun (Camb); 2020 Aug; 56(66):9433-9436. PubMed ID: 32687130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved tumor-targeting MRI contrast agents: Gd(DOTA) conjugates of a cycloalkane-based RGD peptide.
    Park JA; Lee YJ; Ko IO; Kim TJ; Chang Y; Lim SM; Kim KM; Kim JY
    Biochem Biophys Res Commun; 2014 Dec; 455(3-4):246-50. PubMed ID: 25449282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual-Stimuli-Responsive Multifunctional Gd
    Kuang Y; Zhang Y; Zhao Y; Cao Y; Zhang Y; Chong Y; Pei R
    ACS Appl Mater Interfaces; 2020 Aug; 12(32):35928-35939. PubMed ID: 32686939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioresponsive, cell-penetrating, and multimeric MR contrast agents.
    Major JL; Meade TJ
    Acc Chem Res; 2009 Jul; 42(7):893-903. PubMed ID: 19537782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of multimerization of a linear Arg-Gly-Asp peptide on integrin binding affinity and specificity.
    Jin ZH; Furukawa T; Waki A; Akaji K; Coll JL; Saga T; Fujibayashi Y
    Biol Pharm Bull; 2010; 33(3):370-8. PubMed ID: 20190395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
    Caravan P
    Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications.
    Aime S; Castelli DD; Crich SG; Gianolio E; Terreno E
    Acc Chem Res; 2009 Jul; 42(7):822-31. PubMed ID: 19534516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gd3+ cFLFLFK conjugate for MRI: a targeted contrast agent for FPR1 in inflammation.
    Stasiuk GJ; Smith H; Wylezinska-Arridge M; Tremoleda JL; Trigg W; Luthra SK; Morisson Iveson V; Gavins FN; Long NJ
    Chem Commun (Camb); 2013 Jan; 49(6):564-6. PubMed ID: 23208551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel plectin/integrin-targeted bispecific molecular probe for magnetic resonance/near-infrared imaging of pancreatic cancer.
    Wang Q; Yan H; Jin Y; Wang Z; Huang W; Qiu J; Kang F; Wang K; Zhao X; Tian J
    Biomaterials; 2018 Nov; 183():173-184. PubMed ID: 30172243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction Mechanism and Clustering among RGD Peptides and Integrins.
    Dong X; Yu Y; Wang Q; Xi Y; Liu Y
    Mol Inform; 2017 May; 36(5-6):. PubMed ID: 28004516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gd-EDDA/HYNIC-RGD as an MR molecular probe imaging integrin alphanubeta3 receptor-expressed tumor-MR molecular imaging of angiogenesis.
    Huo T; Du X; Zhang S; Liu X; Li X
    Eur J Radiol; 2010 Feb; 73(2):420-7. PubMed ID: 19261416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologically active Arg-Gly-Asp oligopeptides assume a type II beta-turn in solution.
    Johnson WC; Pagano TG; Basson CT; Madri JA; Gooley P; Armitage IM
    Biochemistry; 1993 Jan; 32(1):268-73. PubMed ID: 8418846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodistribution and clearance of 99mTc-labeled Arg-Gly-Asp (RGD) peptide in rats with ischemic acute renal failure.
    Noiri E; Goligorsky MS; Wang GJ; Wang J; Cabahug CJ; Sharma S; Rhodes BA; Som P
    J Am Soc Nephrol; 1996 Dec; 7(12):2682-8. PubMed ID: 8989749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promising strategies for Gd-based responsive magnetic resonance imaging contrast agents.
    Shen C; New EJ
    Curr Opin Chem Biol; 2013 Apr; 17(2):158-66. PubMed ID: 23141598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural analysis of integrin recognition and the inhibition of integrin-mediated cell functions by novel nonpeptidic surrogates of the Arg-Gly-Asp sequence.
    Greenspoon N; Hershkoviz R; Alon R; Varon D; Shenkman B; Marx G; Federman S; Kapustina G; Lider O
    Biochemistry; 1993 Feb; 32(4):1001-8. PubMed ID: 8093840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards MRI contrast agents responsive to Ca(II) and Mg(II) ions: metal-induced oligomerization of dota-bisphosphonate conjugates.
    Kubíček V; Vitha T; Kotek J; Hermann P; Vander Elst L; Muller RN; Lukeš I; Peters JA
    Contrast Media Mol Imaging; 2010; 5(5):294-6. PubMed ID: 20973114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molybdenum Dioxide (MoS₂)/Gadolinium (Gd) Containing Arginine-Glycine-Aspartic Acid (RGD) Sequences as New Nano-Contrast Agent for Cancer Magnetic Resonance Imaging (MRI).
    Hao X; Li W
    J Nanosci Nanotechnol; 2021 Mar; 21(3):1403-1412. PubMed ID: 33404402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual-targeting of αvβ3 and galectin-1 improves the specificity of paramagnetic/fluorescent liposomes to tumor endothelium in vivo.
    Kluza E; Jacobs I; Hectors SJ; Mayo KH; Griffioen AW; Strijkers GJ; Nicolay K
    J Control Release; 2012 Mar; 158(2):207-14. PubMed ID: 22079810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solution structures and integrin binding activities of an RGD peptide with two isomers.
    Assa-Munt N; Jia X; Laakkonen P; Ruoslahti E
    Biochemistry; 2001 Feb; 40(8):2373-8. PubMed ID: 11327857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.